79349337 - BIONTECH

Information

  • Trademark
  • 79349337
  • Serial Number
    79349337
  • Registration Number
    7129113
  • Filing Date
    December 28, 2021
    2 years ago
  • Registration Date
    August 08, 2023
    a year ago
  • Transaction Date
    November 13, 2023
    a year ago
  • Status Date
    August 08, 2023
    a year ago
  • Published for Opposition Date
    May 23, 2023
    a year ago
  • Location Date
    August 08, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    RENNEKER, CHRISTOPHER
  • Attorney Docket Number
    3814.0430000
    Attorney Name
    Monica Riva Talley
    Law Office Assigned Location Code
    N30
  • Owners
Mark Drawing Code
4000
Mark Identification
BIONTECH
Case File Statements
  • GS0091: Downloadable mobile applications for enabling healthcare professionals and patients to access information on pharmaceutical, medical and vaccine products and services; downloadable computer software for enabling healthcare professionals and patients to access information on pharmaceutical, medical and vaccine products and services; downloadable e-commerce computer software for enabling users to perform electronic business transactions via a global computer network
  • GS0051: Pharmaceutical products for the prevention and treatment of cancer, infectious diseases, and immunological diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; vaccines; chemical reagents used for medical purposes; biochemical reagents used for purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes; cell based immune therapeutics for treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; diagnostic preparations for clinical or medical laboratory use
  • PM0001: BIO AND TECH
  • GS0351: Business advisory services in the field of electronic commerce; providing business information in the field of electronic commerce; providing business information, namely, customer information on pharmaceutical and medical products through an on-line computer network; wholesale and retail store services featuring pharmaceutical products, medicinal preparations, and medical supplies
  • GS0011: Chemicals for use in pharmaceutical industry; active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines; adjuvants for use in manufacture of vaccines; nucleic acids, proteins and peptides for laboratory use; diagnostic preparations for scientific or research use other than for medical purposes
  • GS0441: Medical, hygienic and beauty care; health care; providing medical information to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical products, medical diseases and disorders and related treatments via the Internet; gene and cell therapy; medical and psychological counselling services; medical services, namely, providing therapies for treating cancer, infectious diseases and immunological diseases; veterinary services, namely, providing therapies for treating cancer, infectious diseases, and immunological diseases; medical and pharmaceutical consultation; medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposes
  • GS0101: Medical diagnostic devices for analysis of body fluids and biopsies for diagnosis and monitoring of cancer, infectious diseases, and immunological diseases; medical diagnostic devices for analysis of body fluids and biopsies for patient stratification
  • GS0421: Medical and scientific research in the field of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; providing medical and scientific research information, consultancy, and advisory services, all in the fields of medical and scientific research in the field of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; medical and scientific research services by compiling data for clinical trials and drug admission
Case File Event Statements
  • 11/13/2023 - a year ago
    34 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 11/13/2023 - a year ago
    33 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 11/8/2023 - a year ago
    32 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 9/25/2023 - a year ago
    31 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/25/2023 - a year ago
    30 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 9/25/2023 - a year ago
    29 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 8/8/2023 - a year ago
    28 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 8/8/2023 - a year ago
    27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/31/2023 - a year ago
    26 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 5/23/2023 - a year ago
    25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/23/2023 - a year ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/3/2023 - a year ago
    23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 5/3/2023 - a year ago
    22 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 5/3/2023 - a year ago
    21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/18/2023 - a year ago
    20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/18/2023 - a year ago
    19 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/18/2023 - a year ago
    18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/18/2023 - a year ago
    17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/18/2023 - a year ago
    16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/31/2023 - a year ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/31/2023 - a year ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/31/2023 - a year ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/10/2023 - a year ago
    12 - REFUSAL PROCESSED BY IB Type: RFNP
  • 12/28/2022 - a year ago
    11 - CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: CORN
  • 12/17/2022 - 2 years ago
    10 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 12/16/2022 - 2 years ago
    9 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 11/20/2022 - 2 years ago
    8 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 10/5/2022 - 2 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 10/4/2022 - 2 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/30/2022 - 2 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/20/2022 - 2 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 9/16/2022 - 2 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/15/2022 - 2 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 9/15/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR